Skip to main content

Black Hawk Acquisition Corp

BKHAR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0002000775

No open-market purchases or sales by Black Hawk Acquisition Corp insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.46M in total; no superinvestor holds it.

Other share classesBKHABKHAU

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +2 vs. previous quarter
21
13F valueReported value at the end of Q2 2026
$1.46M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding BKHAR, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding BKHAR at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Black Hawk Acquisition Corp insiders from Form 4, newest first.

See all insider trades

No open-market purchases or sales by Black Hawk Acquisition Corp insiders are on file.

Top 10 13F holders, Q2 2026

The largest institutional positions in Black Hawk Acquisition Corp at the end of Q2 2026; share changes are against Q1 2026.

See all 21 holders
Institutions holding BKHAR in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Harraden Circle Investments, LLC249,020$383.5K0.05%00.0%Unchanged
Highbridge Capital Management LLC228,133$337.6K0.01%+85,589+60.0%Added
CNH Partners LLC86,012$132.5K0.00%00.0%Unchanged
Rivernorth Capital Management, LLC62,997$91.3K0.00%00.0%Unchanged
Clear Street Group Inc.54,300$83.6K0.00%+10,005+22.6%Added
Shaolin Capital Management LLC53,041$81.7K0.00%+375+0.7%Added
Boothbay Fund Management, LLC35,375$54.5K0.00%00.0%Unchanged
Whitebox Advisors LLC25,000$38.5K0.00%00.0%Unchanged
Toronto Dominion Bank20,000$30.8K0.00%−117,294−85.4%Reduced
Polar Asset Management Partners Inc.20,000$30.8K0.00%00.0%Unchanged